Clinical Trials Directory

Trials / Conditions / Adrenomyeloneuropathy

Adrenomyeloneuropathy

13 registered clinical trials studyying Adrenomyeloneuropathy — 3 currently recruiting.

StatusTrialSponsorPhase
WithdrawnStudy to Assess PXL770 in Subjects With Adrenomyeloneuropathy (AMN) Form of X-linked Adrenoleukodystrophy (X-A
NCT05146284
Poxel SAPhase 2
RecruitingHome Exercise for Individuals with Neurodegenerative Disease
NCT05443906
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.N/A
RecruitingModeling Macrophages Activation Pattern in X-linked Adrenoleukodystrophy, Metachromatic Leukodystrophy and Adu
NCT04925349
Assistance Publique - Hôpitaux de Paris—
CompletedPlasma Exchange With Albumin in AMN Patients
NCT04303416
Pujol, Aurora, M.D.Phase 2 / Phase 3
CompletedRepetitive Transcranial Magnetic Stimulation as Therapy in Hereditary Spastic Paraplegia and Adrenomyeloneurop
NCT03627416
Jakub AntczakN/A
CompletedLeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies
NCT02699190
Children's Hospital of Philadelphia—
RecruitingThe Myelin Disorders Biorepository Project
NCT03047369
Children's Hospital of Philadelphia—
CompletedEffect of Pioglitazone Administered to Patients With Adrenomyeloneuropathy
NCT03864523
Pujol, Aurora, M.D.Phase 2
CompletedMD1003-AMN MD1003 in Adrenomyeloneuropathy
NCT02961803
MedDay Pharmaceuticals SAPhase 2 / Phase 3
WithdrawnSafety and Pharmacodynamic Study of Sobetirome in X-Linked Adrenoleukodystrophy (X-ALD)
NCT01787578
Thomas S. ScanlanPhase 1
CompletedA Clinical Trial for AMN: Validation of Biomarkers of Oxidative Stress, Efficacy and Safety of a Mixture of An
NCT01495260
Pujol, Aurora, M.D.Phase 2
CompletedThe Effect of Bezafibrate on the Level of Very Long Chain Fatty Acids (VLCFA) in X-linked Adrenoleukodystrophy
NCT01165060
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)N/A
TerminatedA Phase III Trial of Lorenzo's Oil in Adrenomyeloneuropathy
NCT00545597
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Phase 3